YOLFTbeta
68

Taiwan Bio Therapeutics Co., Ltd

6892 · TWO · Healthcare / Biotechnology

25.80TWD-0.10 (-0.39%)

Price History

Full chart

Market Stats

Previous Close25.90
Open25.90
Day Range25.50 – 25.90
52-Week Range23.55 – 30.50
Volume63.01K
Market Cap2.46B
P/E (TTM)0.00
Forward P/E0.00
EPS-4.22
Dividend Yield0.00%
50-Day Avg25.52
200-Day Avg27.00

About

Taiwan Bio Therapeutics Co., Ltd., regenerative medicine company, focuses on the development of new cell medicines. It offers medicines for degenerative diseases, cardiovascular diseases, diabetes complications, and autoimmune diseases. The company was founded in 2014 and is based in Taipei, Taiwan.

Company Details

Financials

Income Statement

Currency: TWD2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-27.16M44.74M85.47M105.09M50.43M
Growth (%)--+64.76%+91.02%+22.96%-52.02%
Cost of Revenue-4.51M13.08M9.11M49.02M18.29M
Gross Profit-22.65M31.67M76.36M56.07M32.14M
Gross Margin-83.39%70.77%89.34%53.35%63.74%
Operating Expense-109.99M214.26M288.56M407.51M416.41M
Operating Income-34.92M-87.34M-182.60M-212.20M-351.44M-384.26M
Operating Margin--321.61%-408.09%-248.28%-334.41%-762.04%
EBITDA-32.27M-58.44M-129.47M-145.97M-247.39M-249.16M
EBITDA Margin--215.18%-289.34%-170.79%-235.40%-494.11%
Net Income-35.04M-90.20M-188.56M-217.51M-351.80M-381.65M
Net Income Margin--332.13%-421.41%-254.49%-334.75%-756.85%
R&D31.39M92.56M181.56M244.65M345.62M341.95M
R&D as % of Total Revenue-340.84%405.76%286.24%328.86%678.13%
Interest Expense117.00K2.86M5.42M5.31M5.21M7.09M
Interest Expense % of Total Revenue-10.52%12.11%6.21%4.96%14.05%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-199.63M590.13M871.01M941.76M1.47B1.35B
Total Liabilities-132.45M333.63M344.18M328.47M380.58M625.12M
Total Equity-67.18M256.50M526.83M613.29M1.09B729.60M
Cash-36.50M59.70M245.89M248.14M677.69M290.39M
Total Debt-3.71M291.26M286.56M268.62M316.05M-
Net Debt--32.79M231.56M40.67M20.48M-361.64M-

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--30.36M-59.16M-139.99M-166.55M-252.40M-212.31M
Investing Cash Flow--24.50M-178.97M-103.17M-119.23M-104.52M-
Financing Cash Flow-68.83M261.33M429.35M290.43M786.01M-
Capital Expenditure031.11M174.69M83.18M119.24M110.86M32.11M
Free Cash Flow--61.48M-233.85M-223.16M-285.78M-363.25M-244.42M
FCF to OCF-202.48%395.29%159.42%171.59%143.92%115.12%

Key Statistics & Ratios

Market Cap2.46B
Enterprise Value2.46B
Trailing P/E0.00
Forward P/E0.00
Price / Sales48.14
Price / Book3.25
EPS-4.22
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets0.00%
Shares Outstanding94.02M
Shares Float0
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%